Clarifying the role of values in cost-effectiveness

被引：0
|
作者：
Gusmano, Michael K. [1 ]
Kaebnick, Gregory [2 ]
机构：
[1] Rutgers State Univ, 112 Paterson St, New Brunswick, NJ 08901 USA
[2] Hastings Ctr, Garrison, NY USA
来源：
HEALTH ECONOMICS POLICY AND LAW | 2016年 / 11卷 / 04期
基金：
美国国家科学基金会;
关键词：
LIFE;
D O I：
10.1017/S1744133116000062
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：439 / 443
页数：5
相关论文
共 50 条
  • [1] Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses
    ten Haaf, Kevin
    de Koning, Harry J.
    [J]. JAMA ONCOLOGY, 2016, 2 (02) : 277 - 278
  • [2] The Role of Patient Preferences in Cost-Effectiveness Analysis A Conflict of Values?
    Brazier, John E.
    Dixon, Simon
    Ratcliffe, Julie
    [J]. PHARMACOECONOMICS, 2009, 27 (09) : 705 - 712
  • [3] The Role of Patient Preferences in Cost-Effectiveness AnalysisA Conflict of Values?
    John E. Brazier
    Simon Dixon
    Julie Ratcliffe
    [J]. PharmacoEconomics, 2009, 27 : 705 - 712
  • [4] Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses Reply
    Goffin, John R.
    Flanagan, William M.
    Evans, William K.
    [J]. JAMA ONCOLOGY, 2016, 2 (02) : 278 - 279
  • [5] Cost-effectiveness analysis: role and implications
    Marsden, G.
    Wonderling, D.
    [J]. PHLEBOLOGY, 2013, 28 : 135 - 140
  • [6] Role of prevention: cost-effectiveness of prevention
    Berrino, F
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 245 - 248
  • [7] Heath State Utility Values for Cost-Effectiveness Models
    Jonathan Karnon
    [J]. PharmacoEconomics, 2017, 35 : 1 - 3
  • [8] Heath State Utility Values for Cost-Effectiveness Models
    Karnon, Jonathan
    [J]. PHARMACOECONOMICS, 2017, 35 : S1 - S3
  • [9] Cost, Effectiveness, and Cost-Effectiveness
    Diamond, George A.
    Kaul, Sanjay
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 49 - 54
  • [10] Effectiveness of cost-effectiveness
    Huda, Ahmed S.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2012, 200 (06) : 513 - 513
12345